BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

357 related articles for article (PubMed ID: 7373331)

  • 1. Patient-specific anti=acetylcholine receptor antibody patterns in myasthenia gravis.
    Savage-Marengo T; Harrison R; Lunt GG; Behan PO
    J Neurol Neurosurg Psychiatry; 1980 Apr; 43(4):316-20. PubMed ID: 7373331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myasthenia gravis: antibodies to acetylcholine receptor with human and rat antigens.
    Oda K; Goto I; Kuroiwa Y; Onoue K; Ito Y
    Neurology; 1980 May; 30(5):543-6. PubMed ID: 7189261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis without acetylcholine-receptor antibody: a distinct disease entity.
    Mossman S; Vincent A; Newsom-Davis J
    Lancet; 1986 Jan; 1(8473):116-9. PubMed ID: 2417076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-acetylcholine receptor antibodies.
    Vincent A; Newsom Davis J
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):590-600. PubMed ID: 7400823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis.
    Aharonov A; Abramsky O; Tarrab-Hazdai R; Fuchs S
    Lancet; 1975 Aug; 2(7930):340-2. PubMed ID: 51144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte responsiveness to acetylcholine receptor in rats with experimental autoimmune myasthenia gravis.
    Noguchi SA; Drachman DB; Adams RN; Hirsch RL
    Ann Neurol; 1980 Jul; 8(1):32-7. PubMed ID: 7406445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of acetylcholine receptor loss in myasthenia gravis.
    Drachman DB; Adams RN; Stanley EF; Pestronk A
    J Neurol Neurosurg Psychiatry; 1980 Jul; 43(7):601-10. PubMed ID: 6249894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acetylcholine receptor antibody and clinical response to thymectomy in myasthenia gravis.
    Vincent A; Newsom-Davis J; Newton P; Beck N
    Neurology; 1983 Oct; 33(10):1276-82. PubMed ID: 6684222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance in neonatal myasthenia gravis of inhibitory effect of amniotic fluid on binding of antibodies to acetylcholine receptor.
    Abramsky O; Brenner T; Lisak RP; Zeidman A; Beyth Y
    Lancet; 1979 Dec 22-29; 2(8156-8157):1333-5. PubMed ID: 92675
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Spectrotypic analysis of antibodies to acetylcholine receptors in experimental autoimmune myasthenia gravis.
    Bionda A; De Baets MH; Tzartos SJ; Lindstrom JM; Weigle WO; Theophilopoulos AN
    Clin Exp Immunol; 1984 Jul; 57(1):41-50. PubMed ID: 6611231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of antigenic sources for acetylcholine receptor antibody assays in myasthenia gravis.
    McAdams MW; Roses AD
    Ann Neurol; 1980 Jul; 8(1):61-6. PubMed ID: 6773466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic difference of acetylcholine receptor between single and multiple form endplates of human extraocular muscle.
    Oda K; Shibasaki H
    Brain Res; 1988 May; 449(1-2):337-40. PubMed ID: 2456129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between anti-acetylcholine receptor antibody levels and neuromuscular function in chronically myasthenic rats.
    Gallant PE
    J Neurol Sci; 1982 Apr; 54(1):129-41. PubMed ID: 6281392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myasthenia gravis: antibodies to acetylcholine receptor in ocular myasthenia gravis.
    Oda K; Ito Y
    J Neurol; 1981; 225(4):251-8. PubMed ID: 6169804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-acetylcholine receptor antibody titres in the sera of myasthenia patients treated with plasma exchange combined with immunosuppressive therapy.
    Carter B; Harrison R; Lunt GG; Behan PO; Simpson JA
    J Neurol Neurosurg Psychiatry; 1980 May; 43(5):397-402. PubMed ID: 7420089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma exchange in myasthenia gravis: effect on anti-AChR antibodies and other autoantibodies.
    Thorlacius S; Lefvert AK; Aarli JA; Gilhus NE; Halvorsen K; Hofstad H; Matre R; Tönder O
    Acta Neurol Scand; 1986 Dec; 74(6):486-90. PubMed ID: 3825504
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to the acetylcholine receptor in myasthenic dogs.
    Garlepp M; Farrow B; Kay P; Dawkins RL
    Immunology; 1979 Aug; 37(4):807-10. PubMed ID: 500127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acetylcholine receptor antibody characteristics in myasthenia gravis. III. Patients with low anti-AChR antibody levels.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1985 Jun; 60(3):631-6. PubMed ID: 2410169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-acetylcholine-receptor antibody concentrations after thymectomy in patients with myasthenia gravis.
    Seybold ME; Baergen RN; Nave B; Lindstrom JM
    Br Med J; 1978 Oct; 2(6144):1051-3. PubMed ID: 709215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.